We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgical Robot with Humanoid-Shaped Arms Replicates Surgeon’s Motions

By HospiMedica International staff writers
Posted on 29 Jun 2022

Robot-assisted surgery is regarded as a must-have by doctors and patients everywhere, due to advances in precision and dexterity, superior control, device multi-functionality, ergonomics, and avoidance of hand tremor and fulcrum effects. More...

Yet even today’s gold-standard solutions remain a mixed offering. Despite being mainstays of minimally-invasive surgery, many robotic procedures require multi-port access and provide limited maneuverability to the surgeon – who is furthermore required to master a massively complex, unintuitive user interface. Due to these and other limitations, these procedures have not been proven to substantially reduce complication rates. Now, the first and only FDA-authorized surgical robot with humanoid-shaped arms designed to replicate the motions and capabilities of a surgeon’s arms provides outstanding surgical and ergonomics capabilities while keeping cost and footprint to a minimum.

The Hominis Surgical System for robotic-assisted transvaginal hysterectomy from Memic Innovative Surgery Ltd. (Tel Aviv, Israel) is the first and only FDA-authorized surgical robot that features miniature humanoid-shaped arms, with shoulder, elbow, and wrist joints that provide high dexterity and unprecedented articulation. The Hominis System is designed to replicate the motions and capabilities of a surgeon's arms. Multiple instruments can be introduced into the body through a single portal and the unprecedented articulation offers optimal access and working angles.

Hominis requires a much smaller footprint and costs significantly less than conventional robotic systems, making it possible for more hospitals and ambulatory surgery centers to acquire the system and offer more patients the benefits of less invasive robotic surgery. Hominis was granted de novo marketing authorization from the FDA in February 2021. Two hospitals have successfully completed the first U.S. patient procedures using the Hominis Surgical System for robotic-assisted transvaginal hysterectomy.

"It is very encouraging to see the first two U.S. commercial sites actively performing benign gynecological procedures using our Hominis System and we are grateful for their support," said Dvir Cohen, president and chief executive officer of Memic. "Hominis is well positioned as a disruptive technology that will transform the way surgeons perform minimally invasive robotic-assisted procedures."

Related Links:
Memic Innovative Surgery Ltd.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.